However, MyD88 is a required adapter protein in most, but not all, LPS- and IL-1β-activated signaling pathways, making it the most reasonable first target for in vivo studies aimed at determining a potential role for TLR and/or IL1R1 activation in FOP. This evidence concerns the gene IL1R1 and fibrodysplasia ossificans progressiva.